Development of an <it>in vitro </it>cleavage assay system to examine vaccinia virus I7L cysteine proteinase activity
<p>Abstract</p> <p>Through the use of transient expression assays and directed genetics, the vaccinia virus (VV) I7L gene product has been implicated as the major maturational proteinase required for viral core protein cleavage to occur during virion assembly. To confirm this hypot...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2005-08-01
|
| Series: | Virology Journal |
| Online Access: | http://www.virologyj.com/content/2/1/63 |
| _version_ | 1818229566126161920 |
|---|---|
| author | Hruby Dennis E Byrd Chelsea M |
| author_facet | Hruby Dennis E Byrd Chelsea M |
| author_sort | Hruby Dennis E |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Through the use of transient expression assays and directed genetics, the vaccinia virus (VV) I7L gene product has been implicated as the major maturational proteinase required for viral core protein cleavage to occur during virion assembly. To confirm this hypothesis and to enable a biochemical examination of the I7L cysteine proteinase, an <it>in vitro </it>cleavage assay was developed. Using extracts of VV infected cells as the source of enzyme, reaction conditions were developed which allowed accurate and efficient cleavage of exogenously added core protein precursors (P4a, P4b and P25K). The cleavage reaction proceeded in a time-dependent manner and was optimal when incubated at 25°C. I7L-mediated cleavage was not affected by selected inhibitors of metalloproteinases, aspartic acid proteinases or serine proteinases (EDTA, pepstatin, and PMSF, respectively), but was sensitive to several general cysteine proteinase inhibitors (E-64, EST, Iodoacetic acid, and NEM) as well as the I7L active site inhibitor TTP-6171 [C. Byrd <it>et al</it>., J. Virol. 78:12147–12156 (2004)]. Finally, in antibody pull down experiments, it could be demonstrated that monospecific αI7L serum depleted the enzyme activity whereas control sera including αG1L, directed against the VV metalloproteinase, did not. Taken together, these data provide biochemical evidence that I7L is a cysteine proteinase which is directly involved in VV core protein cleavage. Furthermore, establishment of this I7L-mediated <it>in vitro </it>cleavage assay should enable future studies into the enzymology and co-factor requirements of the proteolysis reaction, and facilitate antiviral drug development against this essential target.</p> |
| first_indexed | 2024-12-12T10:20:38Z |
| format | Article |
| id | doaj.art-daa4873130f2432694d155e2f79e2918 |
| institution | Directory Open Access Journal |
| issn | 1743-422X |
| language | English |
| last_indexed | 2024-12-12T10:20:38Z |
| publishDate | 2005-08-01 |
| publisher | BMC |
| record_format | Article |
| series | Virology Journal |
| spelling | doaj.art-daa4873130f2432694d155e2f79e29182022-12-22T00:27:33ZengBMCVirology Journal1743-422X2005-08-01216310.1186/1743-422X-2-63Development of an <it>in vitro </it>cleavage assay system to examine vaccinia virus I7L cysteine proteinase activityHruby Dennis EByrd Chelsea M<p>Abstract</p> <p>Through the use of transient expression assays and directed genetics, the vaccinia virus (VV) I7L gene product has been implicated as the major maturational proteinase required for viral core protein cleavage to occur during virion assembly. To confirm this hypothesis and to enable a biochemical examination of the I7L cysteine proteinase, an <it>in vitro </it>cleavage assay was developed. Using extracts of VV infected cells as the source of enzyme, reaction conditions were developed which allowed accurate and efficient cleavage of exogenously added core protein precursors (P4a, P4b and P25K). The cleavage reaction proceeded in a time-dependent manner and was optimal when incubated at 25°C. I7L-mediated cleavage was not affected by selected inhibitors of metalloproteinases, aspartic acid proteinases or serine proteinases (EDTA, pepstatin, and PMSF, respectively), but was sensitive to several general cysteine proteinase inhibitors (E-64, EST, Iodoacetic acid, and NEM) as well as the I7L active site inhibitor TTP-6171 [C. Byrd <it>et al</it>., J. Virol. 78:12147–12156 (2004)]. Finally, in antibody pull down experiments, it could be demonstrated that monospecific αI7L serum depleted the enzyme activity whereas control sera including αG1L, directed against the VV metalloproteinase, did not. Taken together, these data provide biochemical evidence that I7L is a cysteine proteinase which is directly involved in VV core protein cleavage. Furthermore, establishment of this I7L-mediated <it>in vitro </it>cleavage assay should enable future studies into the enzymology and co-factor requirements of the proteolysis reaction, and facilitate antiviral drug development against this essential target.</p>http://www.virologyj.com/content/2/1/63 |
| spellingShingle | Hruby Dennis E Byrd Chelsea M Development of an <it>in vitro </it>cleavage assay system to examine vaccinia virus I7L cysteine proteinase activity Virology Journal |
| title | Development of an <it>in vitro </it>cleavage assay system to examine vaccinia virus I7L cysteine proteinase activity |
| title_full | Development of an <it>in vitro </it>cleavage assay system to examine vaccinia virus I7L cysteine proteinase activity |
| title_fullStr | Development of an <it>in vitro </it>cleavage assay system to examine vaccinia virus I7L cysteine proteinase activity |
| title_full_unstemmed | Development of an <it>in vitro </it>cleavage assay system to examine vaccinia virus I7L cysteine proteinase activity |
| title_short | Development of an <it>in vitro </it>cleavage assay system to examine vaccinia virus I7L cysteine proteinase activity |
| title_sort | development of an it in vitro it cleavage assay system to examine vaccinia virus i7l cysteine proteinase activity |
| url | http://www.virologyj.com/content/2/1/63 |
| work_keys_str_mv | AT hrubydennise developmentofanitinvitroitcleavageassaysystemtoexaminevacciniavirusi7lcysteineproteinaseactivity AT byrdchelseam developmentofanitinvitroitcleavageassaysystemtoexaminevacciniavirusi7lcysteineproteinaseactivity |